New open drug activity data at EBI

doi:10.1186/1752-153X-3-S1-O3

Chemistry Central Journal

Volume 3
Suppl 1

Viewing options:

Abstract
Full text
PDF (60KB)

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
Other articles by authors
on Google Scholar

Steinbeck C
Al-Lazikani B
Hermjakob H
Overington J
Thornton J

on PubMed

Steinbeck C
Al-Lazikani B
Hermjakob H
Overington J
Thornton J
Related articles/pages
on Google

on Google Scholar

Tools:

Post to:

This article is part of the supplement: 4th German Conference on Chemoinformatics: 22. CIC-Workshop .

Oral presentation

New open drug activity data at EBI

C Steinbeck, B Al-Lazikani, H Hermjakob, J Overington and J Thornton

European Bioinformatics Institute, Hinxton, Cambridge, CB10 1SD, UK

corresponding author email

from 4th German Conference on Chemoinformatics
Goslar, Germany. 9–11 November 2008

Chemistry Central Journal 2009, 3(Suppl 1):O3doi:10.1186/1752-153X-3-S1-O3


Published:	5 June 2009

First paragraph (this article has no abstract)

The Wellcome Trust has awarded £4.7 million to the European Bioinformatics Institute (EBI) to support the transfer of a large collection of information on the properties and activities of drugs and a large set of drug-like small molecules from BioFocus DPI, part of the publicly listed company Galapagos to the public domain.